For circRNA–miRNA cooperation, multi-omics data in ovarian cancer show that panels combining circular RNAs with miRNAs can outperform CA125/HE4 in small cohorts and map to MAPK/Wnt/ErbB signaling–supporting the rationale for combined signatures in AM [92]. The gene discussed is WFDC2; the disease is ovarian carcinoma.